Platelets actively sequester angiogenesis regulators
G Lakka Klement, TT Yip, F Cassiola… - Blood, The Journal …, 2009 - ashpublications.org
Clinical trials with antiangiogenic agents have not been able to validate plasma or serum
levels of angiogenesis regulators as reliable markers of cancer presence or therapeutic …
levels of angiogenesis regulators as reliable markers of cancer presence or therapeutic …
Thermodynamic measures of cancer: Gibbs free energy and entropy of protein–protein interactions
…, J Platig, JA Tuszynski, G Lakka Klement - Journal of biological …, 2016 - Springer
… between the PPI entropy and Gibbs free energy for cancer cells, namely G = 7873 − 932S.
Note that in order to relate G and S, we used the absolute value of the Gibbs free energy. This …
Note that in order to relate G and S, we used the absolute value of the Gibbs free energy. This …
Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
The administration of chemotherapy at reduced doses given at regular, frequent time
intervals, termed ‘metronomic’ chemotherapy, presents an alternative to standard maximal …
intervals, termed ‘metronomic’ chemotherapy, presents an alternative to standard maximal …
[HTML][HTML] Design principles for cancer therapy guided by changes in complexity of protein-protein interaction networks
…, JA Tuszynski, EA Rietman, G Lakka Klement - Biology direct, 2015 - Springer
… Formally, an automorphism g of a graph G, has the property that for two vertices u, and v, u
g is adjacent to v g if and only if, v is adjacent to u (ie an edge exists between vertices u and v)…
g is adjacent to v g if and only if, v is adjacent to u (ie an edge exists between vertices u and v)…
[HTML][HTML] Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology
…, R Demlova, B Bencsikova, GL Klement… - Journal of hematology & …, 2013 - Springer
With the recent addition of anti-angiogenic agents to cancer treatment, the angiogenesis
regulators in platelets are gaining importance. Platelet factor 4 (PF-4/CXCL4) and Connective …
regulators in platelets are gaining importance. Platelet factor 4 (PF-4/CXCL4) and Connective …
[HTML][HTML] The role of platelets in tumour growth
…, L Zdrazilova-Dubska, GL Klement - … : casopis Ceske a …, 2012 - ncbi.nlm.nih.gov
Platelets, as initial responders to vascular injury, play a very important role in the initial
stages of the haemostatic process. While the role of platelets in coagulation has been well …
stages of the haemostatic process. While the role of platelets in coagulation has been well …
Acidosis downregulates platelet haemostatic functions and promotes neutrophil proinflammatory responses mediated by platelets
…, MA Romaniuk, LP D'Atri, GL Klement… - Thrombosis and …, 2012 - thieme-connect.com
… and α2β1, are not coupled to G-proteins (27). To elucidate whether the differential effect of
pH on alpha granule release was related to a specific G-protein-related signalling pathway, …
pH on alpha granule release was related to a specific G-protein-related signalling pathway, …
[HTML][HTML] Normal wound healing and tumor angiogenesis as a game of competitive inhibition
…, A Abou-Slaybi, O Dodd, O Dashevsky, GL Klement - PLoS …, 2016 - journals.plos.org
Both normal wound healing and tumor angiogenesis are mitigated by the sequential, carefully
orchestrated release of growth stimulators and inhibitors. These regulators are released …
orchestrated release of growth stimulators and inhibitors. These regulators are released …
The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1
…, J Kapelushnik, C Smith, GL Klement - Journal of Pediatric …, 2010 - journals.lww.com
Purpose The role of angiogenesis in the transformation of peripheral neurofibroma (PNF) to
malignant peripheral nerve sheath tumor (MPNST) in neurofibromatosis type 1 (NF1) …
malignant peripheral nerve sheath tumor (MPNST) in neurofibromatosis type 1 (NF1) …
[HTML][HTML] Future paradigms for precision oncology
GL Klement, K Arkun, D Valik, T Roffidal, A Hashemi… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Research has exposed cancer to be a heterogeneous disease with a high degree of inter-tumoral
and intra-tumoral variability. Individual tumors have unique profiles, and these …
and intra-tumoral variability. Individual tumors have unique profiles, and these …